Reports
Sale
Global Autoinjector Market Size, Trends, Report: By Type: Disposable, Reusable; By Application: Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Others; By Route of Administration: Subcutaneous, Intramuscular; By End User: Hospitals, Clinics, Home Care Settings, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Autoinjector Market Outlook
The global autoinjector market size was valued at USD 71.58 billion in 2023. The major industry drivers include the increasing developments in autoinjector design, increased investment in the health care industry, increasing government assistance for favourable reimbursements and increase in preference for disposable autoinjectors. The market is anticipated to grow at a CAGR of 19.1% during the forecast period 2024-2032 to reach a value of USD 345.14 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Disposable Autoinjectors to Augment the Global Autoinjector Industry Growth
Based on type, disposable autoinjectors account for a significant market share of the global autoinjector industry. This can be attributed to their ease of use and the presence of a built-in glass syringe, which eliminates the need for patients with limited dexterity or vision impairments to manually load the glass syringe, making the process more comfortable for them.
As a result, an increase in preference for disposable autoinjectors is expected to aid the market growth. Furthermore, the growing prevalence of rheumatoid arthritis is expected to drive the product demand in the forecast period.
The Asia Pacific to Provide Significant Growth Opportunities to the Global Autoinjector Industry
The Asia Pacific region is expected to witness a rapid growth in the forecast period, indicating a significant potential to contribute to the global autoinjector industry growth. Because of the high prevalence of diabetes and growing healthcare expenditures, a number of prominent autoinjector device manufacturers are being attracted to this region, adding to the market growth. These companies are expanding their presence through a variety of means, including creating sales offices and forming alliances with local pharmaceutical companies, which is expected to drive the growth of the Asia Pacific autoinjector industry in the coming years.
Autoinjector: Market Segmentation
An autoinjector is a medical device that consists of a syringe with a spring-loaded needle and a pre-filled drug dose. Autoinjectors are commonly used to avoid anaphylaxis and provide rapid pain relief. Autoinjectors provide a number of advantages, including reducing needle-related anxiety condition, reducing the danger of needle-stick incidents, assuring dose quality consistency, and assisting with increased efficacy.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By type, the industry is segmented into:
- Disposable
- Reusable
The market can be broadly categorised on the basis of its application into:
- Rheumatoid Arthritis
- Multiple Sclerosis
- Anaphylaxis
- Others
The EMR report looks into the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Prevalence of Anaphylaxis to Bolster the Growth of the Global Autoinjector Industry
The autoinjector industry is expected to grow considerably in the coming years due to the growing anaphylactic cases globally. As the first line of defence, epinephrine is used to treat anaphylaxis. Innovative designs and portable devices such as autoinjectors with two auto injectable doses in one device and epinephrine with improved temperature stability and shelf life are expected to contribute to the market expansion. Furthermore, the market is expected to grow as a result of the increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases. The government policies for favourable reimbursements as well as the rapid technological advancements, such as dosage monitoring, are other growth drivers for the industry.
Key Industry Players in the Global Autoinjector Market
The report presents a detailed analysis of the following key players in the global autoinjector market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Amgen Inc.
- Antares Pharma, Inc.
- Becton, Dickinson and Company
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Autoinjector Market Overview
3.1 Global Autoinjector Market Historical Value (2017-2023)
3.2 Global Autoinjector Market Forecast Value (2024-2032)
4 Global Autoinjector Market Landscape
4.1 Global Autoinjector Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Autoinjector Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Application
4.2.3 Analysis by Route of Administration
4.2.4 Analysis by End User
5 Global Autoinjector Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Autoinjector Market Segmentation
6.1 Global Autoinjector Market by Type
6.1.1 Market Overview
6.1.2 Disposable
6.1.3 Reusable
6.2 Global Autoinjector Market by Application
6.2.1 Market Overview
6.2.2 Rheumatoid Arthritis
6.2.3 Multiple Sclerosis
6.2.4 Anaphylaxis
6.2.5 Others
6.3 Global Autoinjector Market by Route of Administration
6.3.1 Market Overview
6.3.2 Subcutaneous
6.3.3 Intramuscular
6.4 Global Autoinjector Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Home Care Settings
6.4.5 Others
6.5 Global Autoinjector Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Autoinjector Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Autoinjector Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Autoinjector Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Autoinjector Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Autoinjector Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Amgen Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Antares Pharma, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 BD
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Amgen
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Teva Pharmaceutical Industries Ltd
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Eli Lilly and Company
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Ypsomed AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Novartis AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Mylan N.V.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 GlaxoSmithKline plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Johnson & Johnson Services, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Bayer AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Autoinjector Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global autoinjector market reached a value of USD 71.58 billion in 2023.
The market is anticipated to grow at a CAGR of 19.1% during the forecast period of 2024-2032 to reach a value of USD 345.14 billion by 2032.
The major industry drivers include the increasing developments in autoinjector design, increased investment in the health care industry, increasing government assistance for favourable reimbursements, increase in preference for disposable autoinjectors and growing prevalence of rheumatoid arthritis.
The key industry trends for global autoinjector industry are the growing anaphylactic cases and increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Asia Pacific accounting for the significant share in the market.
The significant type of autoinjector available in the industry are disposable and reusable.
The significant segments of the industry on the basis of application are rheumatoid arthritis, multiple sclerosis, and anaphylaxis, among others.
The major players in the industry are Amgen Inc., Antares Pharma, Inc., and Becton, Dickinson and Company, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER